Global Cabozantinib Market Forecast: Innovation and Oncology Advances Set to Drive Strong Growth Through 2032
https://dataintelo.com/report/....global-cabozantinib-
The Cabozantinib Market is positioned for significant expansion, driven by rising cancer prevalence, increased awareness of targeted therapies, and ongoing advancements in oncology research. Cabozantinib, a potent tyrosine kinase inhibitor, has emerged as a crucial treatment option in various cancer types, particularly renal cell carcinoma and hepatocellular carcinoma.